Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: Comparing One Versus Two Doses of Psilocybin

Clinical trial NCT06341426 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06341426
Sponsor: University Health Network, Toronto
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder Depression Treatment-Resistant Depression Mood Disorders

Start date: 2024-02-05
Primary completion: 2026-07-28
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.